Literature DB >> 6470139

Origin of mammalian biliprotein and rearrangement of bilirubin glucuronides in vivo in the rat.

A F McDonagh, L A Palma, J J Lauff, T W Wu.   

Abstract

In hepatobiliary disease bilirubin becomes bound covalently to serum albumin, producing a nondissociable bile pigment-protein complex (biliprotein). To elucidate the mechanism of biliprotein formation we studied the bile pigment composition of blood from animals with experimental cholestasis and carried out comparative studies on the rate of biliprotein formation in vivo and in vitro during incubation of bilirubin glucuronides with albumin. Bile duct ligation in the rat and guinea pig led to rapid accumulation in the circulation of bilirubin, heterogeneous bilirubin esters of glucuronic acid, and a biliprotein that migrated along with albumin on high performance liquid chromatography. When the obstruction was removed, biliprotein remained longer in the circulation than did the other bile pigment species. Biliprotein and heterogeneous bilirubin esters of glucuronic acid were not formed in bile duct-ligated homozygous Gunn rats but they were formed when bilirubin glucuronides were incubated with Sprague-Dawley rat serum or human serum albumin at 37 degrees C in vitro. Bilirubin glucuronide rearrangement in vitro was accompanied by nonenzymic hydrolysis. We conclude that the formation of biliprotein in vivo is probably nonenzymic and suggest that mammalian biliprotein is formed by acyl migration of bilirubin from a bilirubin-glucuronic acid ester to a nucleophilic site on albumin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6470139      PMCID: PMC425230          DOI: 10.1172/JCI111492

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  THE APPARENT HIGH REACTIVITY OF SOME AMINO GROUPS OF BOVINE SERUM ALBUMIN.

Authors:  N M GREEN
Journal:  Biochim Biophys Acta       Date:  1963-08-13

2.  On the fluctuations in the diazo reaction rate and in the bilirubin absorbed on serum proteins during the course of jaundices.

Authors:  D CORA
Journal:  Acta Med Scand       Date:  1952-03-19

3.  A polypeptide conjugate of bilirubin from human bile.

Authors:  H Etter-kjelsaas; C C Kuenzle
Journal:  Biochim Biophys Acta       Date:  1975-07-21

Review 4.  The degradation of haem by mammals and its excretion as conjugated bilirubin.

Authors:  G H Lathe
Journal:  Essays Biochem       Date:  1972       Impact factor: 8.000

5.  Does deconjugation of bilirubin glucuronide occur in obstructive jaundice?

Authors:  G Acocella; L T Tenconi; R Armas-Merino; S Raia; B H Billing
Journal:  Lancet       Date:  1968-01-13       Impact factor: 79.321

6.  The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia.

Authors:  J S Weiss; A Gautam; J J Lauff; M W Sundberg; P Jatlow; J L Boyer; D Seligson
Journal:  N Engl J Med       Date:  1983-07-21       Impact factor: 91.245

7.  The nature of four bilirubin fractions from serum and of three bilirubin fractions from bile.

Authors:  C C Kuenzle; C Maier; J R Rüttner
Journal:  J Lab Clin Med       Date:  1966-02

8.  Acetylation of human serum albumin by acetylsalicylic acid.

Authors:  D Hawkins; R N Pinckard; R S Farr
Journal:  Science       Date:  1968-05-17       Impact factor: 47.728

9.  Electrophilic reactions of acyl-linked glucuronides. Formation of clofibrate mercapturate in humans.

Authors:  M Stogniew; C Fenselau
Journal:  Drug Metab Dispos       Date:  1982 Nov-Dec       Impact factor: 3.922

10.  Bilirubin conjugates in bile of man and rat in the normal state and in liver disease.

Authors:  J Fevery; B Van Damme; R Michiels; J De Groote; K P Heirwegh
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

View more
  10 in total

Review 1.  Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.

Authors:  D K Meijer; P van der Sluijs
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

2.  Dynamic aspects of glutathione metabolism in obstructive jaundice.

Authors:  M Hirota; K Sugi; M Inoue
Journal:  J Gastroenterol       Date:  1994-10       Impact factor: 7.527

Review 3.  A review of new approaches to assessing hepatic function in animals.

Authors:  C E Cornelius
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

4.  Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry.

Authors:  A Ding; J C Ojingwa; A F McDonagh; A L Burlingame; L Z Benet
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  Hepatic disposition and biliary excretion of bilirubin and bilirubin glucuronides in intact rats. Differential processing of pigments derived from intra- and extrahepatic sources.

Authors:  J M Crawford; B J Ransil; C S Potter; S V Westmoreland; J L Gollan
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

6.  Non-enzymic hydrolysis of bilirubin mono- and diglucuronide to unconjugated bilirubin in model and native bile systems. Potential role in the formation of gallstones.

Authors:  W Spivak; D DiVenuto; W Yuey
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

7.  Irreversible binding of zomepirac to plasma protein in vitro and in vivo.

Authors:  P C Smith; A F McDonagh; L Z Benet
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

8.  Rapid clearance of a structural isomer of bilirubin during phototherapy.

Authors:  J F Ennever; A T Costarino; R A Polin; W T Speck
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

9.  Analyses of azopigments obtained from the delta fraction of bilirubin from mammalian plasma (mammalian biliprotein).

Authors:  H Yoshida; T Inagaki; M Hirano; T Sugimoto
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

10.  Irreversible binding of tolmetin glucuronic acid esters to albumin in vitro.

Authors:  A Munafo; A F McDonagh; P C Smith; L Z Benet
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.